山(shan)東未(wei)名生物醫藥股份有(you)限公(gong)(gong)(gong)司(si)(si)(以下(xia)簡稱(cheng)“未(wei)名醫藥”或(huo)“公(gong)(gong)(gong)司(si)(si)”)是(shi)未(wei)名集團控股的在深圳證券(quan)交易(yi)所上市的A股公(gong)(gong)(gong)眾公(gong)(gong)(gong)司(si)(si),證券(quan)簡稱(cheng):未(wei)名醫藥,證券(quan)代碼:002581。公(gong)(gong)(gong)司(si)(si)于2015年10月19日經重大資產(chan)重組原(yuan)“淄(zi)博萬昌(chang)科技股份(fen)有限(xian)(xian)(xian)公(gong)司(si)(si)(si)”更名(ming)(ming)而成(cheng)。公(gong)司(si)(si)(si)擁(yong)有未名(ming)(ming)生(sheng)物(wu)醫(yi)藥有限(xian)(xian)(xian)公(gong)司(si)(si)(si)(廈(sha)門)、天津未名(ming)(ming)生(sheng)物(wu)醫(yi)藥有限(xian)(xian)(xian)公(gong)司(si)(si)(si)、北京科興(xing)生(sheng)物(wu)制品有限(xian)(xian)(xian)公(gong)司(si)(si)(si)、山東未名(ming)(ming)天源生(sheng)物(wu)科技有限(xian)(xian)(xian)公(gong)司(si)(si)(si)、北京未名(ming)(ming)西大生(sheng)物(wu)科技有限(xian)(xian)(xian)公(gong)司(si)(si)(si)、合(he)肥北大未名(ming)(ming)生(sheng)物(wu)制藥有限(xian)(xian)(xian)公(gong)司(si)(si)(si)等下屬企業或生(sheng)產基地。
未名(ming)(ming)集團(tuan)三大(da)夢想之一是“解決中(zhong)國健康(kang)問題”:通(tong)(tong)過(guo)(guo)(guo)發展生(sheng)(sheng)物醫(yi)(yi)藥(yao)(yao)(yao)(yao)產業(ye),建(jian)(jian)(jian)(jian)立(li)健康(kang)產品(pin)供給體(ti)系;通(tong)(tong)過(guo)(guo)(guo)發展現(xian)代中(zhong)醫(yi)(yi)藥(yao)(yao)(yao)(yao),建(jian)(jian)(jian)(jian)立(li)中(zhong)國特色的(de)(de)健康(kang)服務(wu)體(ti)系;通(tong)(tong)過(guo)(guo)(guo)實(shi)施GHP計劃(hua),建(jian)(jian)(jian)(jian)立(li)生(sheng)(sheng)命健康(kang)管理(li)體(ti)系。未名(ming)(ming)醫(yi)(yi)藥(yao)(yao)(yao)(yao)將(jiang)發展藥(yao)(yao)(yao)(yao)物制造、新藥(yao)(yao)(yao)(yao)研發、產品(pin)配送三大(da)系統,建(jian)(jian)(jian)(jian)成(cheng)完(wan)善的(de)(de)健康(kang)產品(pin)供給體(ti)系,通(tong)(tong)過(guo)(guo)(guo)實(shi)施“百千萬億工程”,到(dao)2030年實(shi)現(xian)以下目標:未名(ming)(ming)醫(yi)(yi)藥(yao)(yao)(yao)(yao)占中(zhong)國醫(yi)(yi)藥(yao)(yao)(yao)(yao)市場總銷售額的(de)(de)10%、占生(sheng)(sheng)物醫(yi)(yi)藥(yao)(yao)(yao)(yao)市場總銷售的(de)(de)50%、上市公司(002581)市值(zhi)超(chao)過(guo)(guo)(guo)一萬億;通(tong)(tong)過(guo)(guo)(guo)建(jian)(jian)(jian)(jian)立(li)新藥(yao)(yao)(yao)(yao)高速公路,未名(ming)(ming)醫(yi)(yi)藥(yao)(yao)(yao)(yao)將(jiang)每年獲(huo)得25張新藥(yao)(yao)(yao)(yao)證書;通(tong)(tong)過(guo)(guo)(guo)國際化的(de)(de)企業(ye)重(zhong)組并購(gou),未名(ming)(ming)醫(yi)(yi)藥(yao)(yao)(yao)(yao)成(cheng)為世界上較大(da)的(de)(de)醫(yi)(yi)藥(yao)(yao)(yao)(yao)企業(ye)集團(tuan)。